Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
-1.72% $5.15
America/New_York / 3 mai 2024 @ 15:59
FUNDAMENTALS | |
---|---|
MarketCap: | 1 772.44 mill |
EPS: | -0.340 |
P/E: | -15.15 |
Earnings Date: | May 08, 2024 |
SharesOutstanding: | 344.16 mill |
Avg Daily Volume: | 0.368 mill |
RATING 2024-05-03 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Buy | |
P/E: | Sell | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -15.15 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.48x |
Company: PE -15.15 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
$11.31 (119.68%) $6.16 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 4.59 - 5.71 ( +/- 10.83%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Kalesnik Laura Marie | Sell | 1 569 | Class A Subordinate Voting Shares |
2024-03-25 | Kalesnik Laura Marie | Sell | 14 219 | Restricted Stock Units |
2024-03-25 | Kalesnik Laura Marie | Buy | 14 219 | Class A Subordinate Voting Shares |
2024-03-26 | Kalesnik Laura Marie | Sell | 3 760 | Class A Subordinate Voting Shares |
2024-03-25 | Hirsh Lawrence Randall | Sell | 17 542 | Restricted Stock Units |
INSIDER POWER |
---|
-92.90 |
Last 98 transactions |
Buy: 860 505 | Sell: 21 399 527 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $5.15 (-1.72% ) |
Volume | 0.140 mill |
Avg. Vol. | 0.368 mill |
% of Avg. Vol | 38.09 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.